about
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situEngineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-NMelanoma NOS1 expression promotes dysfunctional IFN signalingStrategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia.A self-directed method for cell-type identification and separation of gene expression microarrays.Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.Dynamics and potential impact of the immune response to chronic myelogenous leukemiaAn open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancerHuman brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.In vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge modelModeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach.Rational design of combination enzyme therapy for celiac sprue.T cell state transition produces an emergent change detector.Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.A Chinese rhesus macaque (Macaca mulatta) model for vaginal Lactobacillus colonization and live microbicide development.Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques.Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.Development and dynamics of robust T-cell responses to CML under imatinib treatmentAltered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 moleculesIdentification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRExpression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.A theory of immunodominance and adaptive regulation.Immunotherapy biomarkers 2016: overcoming the barriers.Systematic evaluation of immune regulation and modulationMultiplexed tissue biomarker imaging.Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses.IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.A two-layer structure prediction framework for microscopy cell detection.Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a POLE Mutation.Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models.MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab.
P50
Q21092390-5C51E382-1CA3-420F-84EB-6A6EA448AF66Q28484272-6E4B3260-BA7C-48BE-8F85-90511A76BB04Q30357096-63AE81BD-53DB-4FF9-906E-F20C3D25F5EDQ30413226-E0C7F5CA-833E-40BA-A5BE-9ADD4E8A0937Q30984215-560C18CA-1ECD-44EF-8C16-1CA056501B41Q31129201-D0F8A0B3-0A1E-4FD3-AB24-0BC2C527FF47Q33284046-21FD2789-CF7F-4034-8D47-3EE69FD33AF6Q33345245-213247D3-C3EF-4B6B-B4AB-9882F85470D2Q33412123-6DEDE5C6-0230-4857-8D99-B5FE8D24587CQ33767336-36C3A04C-7074-45CF-83A4-8C90DE435E2FQ34198191-F71D95F9-6FAF-4334-873B-7EBB5DD5BB1FQ34241366-93F033C1-84D6-4B9A-9CFF-2387D2724AA6Q34387113-0B89E2FD-7509-4EA3-99E0-3896E2A4054DQ34468868-5D4EE834-5EE9-4516-AB67-654DF4BFDCD2Q34541046-AC545AF2-9D39-49C2-8C3F-2739F6E53974Q34632299-96663430-5F77-4696-B709-353F7B97A8B4Q34695408-A2461A1A-FAA8-473E-878C-53B556D9F5E3Q35415972-CB580ECA-E584-4C8C-9F39-91B261EF1E43Q35575950-5E209D96-2123-4A92-89E2-D608473126BDQ36254221-7C846203-6B18-4B20-8BAA-AB4815D7C6CFQ36265872-F5A733D1-0B41-46D4-A084-040BBF64CD25Q36368332-2417C814-1D4C-4D6E-85ED-B4234D9F049EQ36677315-26CB65D1-BA87-4C73-BBB4-3F9CA3288994Q36721762-F5EFD872-1EF4-4D08-BEBC-13A07F5BADCEQ36824239-28EBC02B-D3A3-47C3-A495-3E91F4137B49Q37126629-0BF0FBA8-85D5-404C-B6E2-4C46549908C2Q37346068-EBCA5899-FB63-4133-A86D-504464AC70A2Q37398406-914631E0-04E6-485F-8F19-9B97B38DFCA3Q37713438-1F4FCDA5-B7A2-47CC-8DB4-DFEE454DAA47Q37713498-86DCE23F-6274-4548-8183-BC62A4FF4031Q38487979-8EDE378B-ADDC-4673-83B1-B9718C14C221Q39741064-99250D29-8138-4ABD-8A4F-34D7C14723BDQ40407642-9976A4C8-525B-4F01-B109-7B8FCA1BA1A2Q42139657-B3C2DD4A-0AD5-4F74-902F-4A63AA27F8EEQ44794043-7A34A501-B07C-44B7-A855-409D11104277Q45956582-7493A46F-EAFF-49FF-B494-2A75DD22539BQ45979172-E4416A5E-1C52-4B5C-AEA0-64EAD605DA3AQ46865382-4B1C9BE4-D204-4F3E-AE74-9AB2401A1388Q47560871-1EF47F80-4A65-45F6-AA9B-91E7637DF6D6Q47563512-CA7B0E37-93D2-4390-84A5-364C4185CC1A
P50
description
researcher
@en
wetenschapper
@nl
name
Peter P Lee
@en
Peter P Lee
@es
Peter P Lee
@nl
type
label
Peter P Lee
@en
Peter P Lee
@es
Peter P Lee
@nl
prefLabel
Peter P Lee
@en
Peter P Lee
@es
Peter P Lee
@nl
P108
P106
P31
P496
0000-0002-2660-4377